Transactions
May 22, 2001
Pillsbury Winthrop: FINANCING MEANS MORE PRESCRIPTIONS FOR BRAIN
San Diego's Xcel Pharmaceuticals Inc. has received $70 million in first round financing. Domain Associates of Princeton, N.J. and New Enterprise Associates of Baltimore were the lead investors.
San Diego's Xcel Pharmaceuticals Inc. has received $70 million in first round financing. Domain Associates of Princeton, N.J. and New Enterprise Associates of Baltimore were the lead investors.
Xcel Pharmaceuticals is a newly-formed company organized to market and sell both proprietary and branded prescription products. The company focuses on the neurology market, where a limit...
Xcel Pharmaceuticals is a newly-formed company organized to market and sell both proprietary and branded prescription products. The company focuses on the neurology market, where a limit...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In